Roser Ferrer (Roser Ferrer-Costa)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Biomedicines

Journal of clinical medicine

Diagnostics (Basel, Switzerland)

International journal of chronic obstructive pulmonary disease

Vall d'Hebron University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vall d'Hebron University Hospital May 05 2003

Spain

Staff :: Clinical Biochemistry-Clinical Laboratories

Publications

Anna Casteràs, Enzamaria Fidilio, Marta Comas, Alba Zabalegui, Vanesa Flores, Marina Giralt, Noelia Díaz-Troyano, Roser Ferrer, Ramón Vilallonga Puy, Andreea Ciudin, Betina Biagetti
Pre-Surgery Cortisol Levels as Biomarker of Evolution after Bariatric Surgery: Weight Loss and Weight Regain. Journal of clinical medicine 13 (17) (2024)
Carmen Llorens-Cebrià, Norberto Núñez-Seral, Yolanda Villena-Ortiz, Irene Martínez-Díaz, Maria José Soler, Roser Ferrer, Maria José Soler, Joan López-Hellín
Trypsin Partially Cleaves Apolipoprotein A-I (ApoA-I) Precursor into Mature ApoA-I Hindering the Quantification of Naturally Occurring ApoA-I Proteoforms by Liquid Chromatography in Multiple Reaction Monitoring Mode Mass Spectrometry (LC-MRM-MS). Journal of the American Society for Mass Spectrometry (2024)
Diana Rafael, Marcelo Guerrero, Adolfo Marican, Diego Arango, Bruno Filipe Carmelino Cardoso Sarmento, Roser Ferrer, Esteban F Durán-Lara, Simon J Clark, Simó Schwartz
Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds. Pharmaceutics 15 (5) (2023)
Jesus Manuel Rivera Esteban, Alba Jiménez-Masip, Sergio Muñoz-Martínez, Salvador Augustin, Rafael A Guerrero, Pablo Gabriel-Medina, Roser Ferrer, Francisco Rodriguez-Frías, Elisabet Turu, Andrés Marco, Juan M Pericàs, null On Behalf Of The Prisonafld Study Group Collaborators
Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study. Journal of clinical medicine 12 (23) (2023)
Jaume Baldirà, Juan Carlos Ruiz-Rodríguez, Adolfo Ruiz-Sanmartin, Luis Chiscano, Alejandro Cortes, Diego Ángeles Sistac, Roser Ferrer, Inma Comas, Yolanda Villena-Ortiz, Maria Nieves Larrosa, Juan José González-López, Ricard Ferrer
Use of Biomarkers to Improve 28-Day Mortality Stratification in Patients with Sepsis and SOFA ≤ 6. Biomedicines 11 (8) (2023)
Selene García-García, Andrea Caballero-Garralda, David Tabernero, María Francesca Cortese, Josep Gregori, Francisco Rodriguez-Algarra, Josep Quer, Mar Riveiro-Barciela, Maria Homs, Ariadna Rando, Beatriz Pacin-Ruiz, Marta Vila, Roser Ferrer, Tomas Pumarola, Maria Buti, Francisco Rodriguez-Frías
Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3' End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients. Biomedicines 10 (5) (2022)
Alba Rojano-Toimil, Jesus Manuel Rivera Esteban, Ramiro Manzano-Nunez, Juan Bañares, David Martinez Selva, Pablo Gabriel-Medina, Roser Ferrer, Juan Manuel Pericàs, Andreea Ciudin
When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD. Journal of clinical medicine 11 (12) (2022)
José Raúl Herance, Queralt Martín-Saladich, Mayra Alejandra Velásquez, Cristina Hernandez, Carolina Aparicio, Clara Ramirez-Serra, Roser Ferrer, Marina Giralt-Arnaiz, Miguel A González Ballester, Juan Manuel Pericàs, Joan Castell-Conesa, Santiago Aguadé-Bruix, Rafael Simò
Identification of Myocardial Insulin Resistance by Using Liver Tests: A Simple Approach for Clinical Practice. International journal of molecular sciences 23 (15) (2022)
Noelia Díaz-Troyano, Pablo Gabriel-Medina, Stephen Weber, Martin Klammer, Raquel Barquín-DelPino, Laura Castillo-Ribelles, Angels Esteban, Manuel Hernández-González, Roser Ferrer, Tomas Pumarola, Francisco Rodriguez-Frías
Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Luisa Martinez-Sanchez, Christa M Cobbaert, Raymond Noordam, Nannette Brouwer, Albert Blanco-Grau, Yolanda Villena-Ortiz, Marc H M Thelen, Roser Ferrer, Ernesto Casis, Francisco Rodríguez-Frias, Wendy P J den Elzen
Indirect determination of biochemistry reference intervals using outpatient data. PloS one 17 (5) (2022)
Pablo Gabriel-Medina, Roser Ferrer, Francisco Rodriguez-Frías, Andreea Ciudin, Salvador Augustin, Jesus Rivera-Esteban, Juan Manuel Pericàs, David Martinez Selva
Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis. Biomedicines 10 (5) (2022)
Albert Blanco-Grau, Pablo Gabriel-Medina, Francisco Rodriguez-Algarra, Yolanda Villena-Ortiz, Rosa Lopez-Martínez, Salvador Augustín, Mónica Pons, Luz-Maria Cruz, Ariadna Rando, Belen Enfedaque, Mar Riveiro, Ernesto Casis, Roser Ferrer, Maria Buti, Francisco Rodriguez-Frias
Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting. Diagnostics (Basel, Switzerland) 11 (12) (2021)
Marina Giralt, Sara Chocron, Roser Ferrer, Gema Ariceta
Plasma intact fibroblast growth factor 23 level is a useful tool for diagnostic approach of renal hypophosphatemia. Pediatric nephrology (Berlin, Germany) 36 (4) (2021)
Irene Belmonte, Alexa Nuñez, Miriam Barrecheguren, Cristina Esquinas, Mònica Pons, Rosa Maria Lopez-Martinez, Gerard Ruiz, Albert Blanco-Grau, Roser Ferrer, Joan Genescà, Marc Miravitlles, Francisco Rodriguez-Frías
Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory. International journal of chronic obstructive pulmonary disease 15 (2020)

Roser Ferrer.css-eqlu8i{font-size:small;padding-left:4px;} (Roser Ferrer-Costa)

Publication Activity (10 Years)

Top Topics

Top Venues

Roser Ferrer (Roser Ferrer-Costa)